{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:54:25Z","timestamp":1776412465584,"version":"3.51.2"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bpa.2009.09.004","type":"journal-article","created":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T04:44:41Z","timestamp":1267245881000},"page":"121-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Regional anaesthesia and anticoagulation"],"prefix":"10.1016","volume":"24","author":[{"given":"Erik","family":"Vandermeulen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpa.2009.09.004_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2253-6-10","article-title":"Incidence of epidural haematoma and neurological injury in cardiovascular patients with epidural analgesia\/anaesthesia: systematic review and meta-analysis","volume":"6","author":"Ruppen","year":"2006","journal-title":"BMC Anesthesiology"},{"key":"10.1016\/j.bpa.2009.09.004_bib2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1213\/00000539-199412000-00024","article-title":"Anticoagulants and spinal-epidural anesthesia","volume":"79","author":"Vandermeulen","year":"1994","journal-title":"Anesthesia & Analgesia"},{"issue":"1","key":"10.1016\/j.bpa.2009.09.004_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00000542-200407000-00023","article-title":"Injuries associated with regional anesthesia in the 1980s and 1990s: a closed claims analysis","volume":"101","author":"Lee","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2009.09.004_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-2007-998902","article-title":"Epidural regional anesthesia and low molecular heparin: pro","volume":"28","author":"Tryba","year":"1993","journal-title":"An\u00e4sthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"4","key":"10.1016\/j.bpa.2009.09.004_bib5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1213\/00000539-199710000-00031","article-title":"Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management","volume":"85","author":"Horlocker","year":"1997","journal-title":"Anesthesia & Analgesia"},{"issue":"6 (Suppl 2)","key":"10.1016\/j.bpa.2009.09.004_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/rapm-00115550-199823062-00009","article-title":"Statistics: detecting a rare adverse drug reaction using spontaneous reports","volume":"23","author":"Schroeder","year":"1998","journal-title":"Regional Anesthesia and Pain Medicine"},{"issue":"5","key":"10.1016\/j.bpa.2009.09.004_bib7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/01.anes.0000265160.32309.10","article-title":"A review of neuraxial epidural morbidity: experience of more than 8,000 cases at a single teaching hospital","volume":"106","author":"Cameron","year":"2007","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.bpa.2009.09.004_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2044.2007.04992.x","article-title":"Major complications of epidural analgesia after surgery: results of a six-year survey","volume":"62","author":"Christie","year":"2007","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1016\/j.bpa.2009.09.004_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/bja\/aen360","article-title":"Major complications of central neuraxial block: report on the third national audit project of the royal college of anaesthetists","volume":"102","author":"Cook","year":"2009","journal-title":"British Journal of Anaesthesia"},{"issue":"4","key":"10.1016\/j.bpa.2009.09.004_bib10","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/00000542-200410000-00021","article-title":"Severe neurological complications after central neuraxial blockades in Sweden 1990\u20131999","volume":"101","author":"Moen","year":"2004","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.bpa.2009.09.004_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000542-200608000-00023","article-title":"Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia\/anesthesia","volume":"105","author":"Ruppen","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2009.09.004_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00001503-199910000-00009","article-title":"Is anticoagulation and central neural blockade a safe combination","volume":"12","author":"Vandermeulen","year":"1999","journal-title":"Current Opinion in Anaesthesiology"},{"issue":"12","key":"10.1016\/j.bpa.2009.09.004_bib13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/BF03013437","article-title":"Epidural anaesthesia and spinal hematoma","volume":"43","author":"Wulf","year":"1996","journal-title":"Canadian Journal of Anaesthesia"},{"issue":"3","key":"10.1016\/j.bpa.2009.09.004_bib14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/bja\/aen170","article-title":"Detection and management of epidural haematomas related to anaesthesia in the UK: a national survey of current practice","volume":"101","author":"Meikle","year":"2008","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"10.1016\/j.bpa.2009.09.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1995.83.1.0001","article-title":"Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome","volume":"83","author":"Lawton","year":"1995","journal-title":"Journal of Neurosurgery"},{"issue":"5","key":"10.1016\/j.bpa.2009.09.004_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S0265021506001918","article-title":"Anticlotting drugs and regional anaesthetic and analgesic techniques: comparative update of the safety recommendations","volume":"24","author":"Llau","year":"2007","journal-title":"European Journal of Anaesthesiology"},{"issue":"11","key":"10.1016\/j.bpa.2009.09.004_bib17","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Medicine"},{"issue":"11","key":"10.1016\/j.bpa.2009.09.004_bib18","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1365-2044.2007.05195.x","article-title":"Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies","volume":"62","author":"Rosencher","year":"2007","journal-title":"Anaesthesia"},{"issue":"6","key":"10.1016\/j.bpa.2009.09.004_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.STR.12.6.879","article-title":"Complications of lumbar puncture followed by anticoagulation","volume":"12","author":"Ruff","year":"1981","journal-title":"Stroke"},{"issue":"5 Pt 2","key":"10.1016\/j.bpa.2009.09.004_bib20","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1007\/BF03011675","article-title":"Impaired haemostasis and regional anaesthesia","volume":"43","author":"Stafford-Smith","year":"1996","journal-title":"Canadian Journal of Anaesthesia"},{"issue":"3","key":"10.1016\/j.bpa.2009.09.004_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0049-3848(02)00031-2","article-title":"Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment","volume":"105","author":"Sanderink","year":"2002","journal-title":"Thrombosis Research"},{"issue":"6 Suppl","key":"10.1016\/j.bpa.2009.09.004_bib22","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1378\/chest.08-0675","article-title":"The perioperative management of antithrombotic therapy: american college of chest physicians evidence-based clinical practice guidelines (8th ed.)","volume":"133","author":"Douketis","year":"2008","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.bpa.2009.09.004_bib23","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2165\/00003495-200262150-00016","article-title":"Danaparoid: a review of its use in thromboembolic and coagulation disorders","volume":"62","author":"Ibbotson","year":"2002","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.bpa.2009.09.004_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2165\/00003495-199754060-00008","article-title":"Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia","volume":"54","author":"Wilde","year":"1997","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.bpa.2009.09.004_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/14656566.1.4.803","article-title":"Danaparoid sodium","volume":"1","author":"Acostamadiedo","year":"2000","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.bpa.2009.09.004_bib26","article-title":"Org31540\/SR90107A","author":"Sanofi-Synthelabo","year":"2001","journal-title":"Clinical Investigator Brochure"},{"issue":"6","key":"10.1016\/j.bpa.2009.09.004_bib27","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1055\/s-0038-1649967","article-title":"Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107\/Org31540) with high affinity to antithrombin III in man","volume":"74","author":"Boneu","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"issue":"11 Suppl","key":"10.1016\/j.bpa.2009.09.004_bib28","first-page":"16","article-title":"Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety","volume":"31","author":"Kwong","year":"2002","journal-title":"The American Journal of Orthopedics"},{"issue":"6","key":"10.1016\/j.bpa.2009.09.004_bib29","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1213\/01.ane.0000287677.95626.60","article-title":"The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study","volume":"105","author":"Singelyn","year":"2007","journal-title":"Anesthesia and Analgesia"},{"issue":"25","key":"10.1016\/j.bpa.2009.09.004_bib30","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1056\/NEJMc070346","article-title":"Heparin-induced thrombocytopenia associated with fondaparinux","volume":"356","author":"Warkentin","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.bpa.2009.09.004_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1160\/TH07-09-0573","article-title":"Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT)","volume":"99","author":"Rota","year":"2008","journal-title":"Thrombosis and Haemostasis"},{"issue":"6 Suppl","key":"10.1016\/j.bpa.2009.09.004_bib32","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: american college of chest physicians evidence-based clinical practice guidelines (8th ed.)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"issue":"26","key":"10.1016\/j.bpa.2009.09.004_bib33","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.bpa.2009.09.004_bib34","author":"FDA"},{"key":"10.1016\/j.bpa.2009.09.004_bib35","author":"Bayer"},{"issue":"12","key":"10.1016\/j.bpa.2009.09.004_bib36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00228-005-0043-5","article-title":"Safety, pharmacodynamics, and pharmacokinetics of BAY 59\u20137939\u2013an oral, direct Factor Xa inhibitor\u2013after multiple dosing in healthy male subjects","volume":"61","author":"Kubitza","year":"2005","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1016\/j.bpa.2009.09.004_bib37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.103.10.1479","article-title":"Recombinant hirudin in clinical practice: focus on lepirudin","volume":"103","author":"Greinacher","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bpa.2009.09.004_bib38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-2002-35283","article-title":"Hirudin in heparin-induced thrombocytopenia","volume":"28","author":"Lubenow","year":"2002","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"3","key":"10.1016\/j.bpa.2009.09.004_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/14779072.2.3.339","article-title":"Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy","volume":"2","author":"Greinacher","year":"2004","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"6","key":"10.1016\/j.bpa.2009.09.004_bib40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mcp.2002.124522","article-title":"Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender","volume":"71","author":"Robson","year":"2002","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"8","key":"10.1016\/j.bpa.2009.09.004_bib41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9149(03)00970-6","article-title":"Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials","volume":"92","author":"Chew","year":"2003","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1016\/j.bpa.2009.09.004_bib42","first-page":"S11","article-title":"Reversing anticoagulants both old and new","volume":"49","author":"Warkentin","year":"2002","journal-title":"Canadian Journal of Anaesthesia"},{"issue":"7","key":"10.1016\/j.bpa.2009.09.004_bib43","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood.V96.7.2373","article-title":"Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance","volume":"96","author":"Eichler","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bpa.2009.09.004_bib44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1517\/14656566.4.5.653","article-title":"Direct thrombin inhibitors","volume":"4","author":"Kaplan","year":"2003","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.bpa.2009.09.004_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1015368126304","article-title":"Argatroban","volume":"13","author":"Kathiresan","year":"2002","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"4","key":"10.1016\/j.bpa.2009.09.004_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2002-34305","article-title":"Monitoring of anticoagulant effects of direct thrombin inhibitors","volume":"28","author":"Fenyvesi","year":"2002","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"3","key":"10.1016\/j.bpa.2009.09.004_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1592\/phco.20.4.318.34881","article-title":"The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction","volume":"20","author":"Swan","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.bpa.2009.09.004_bib48","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2007.02748.x","article-title":"Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial","volume":"5","author":"Eriksson","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"12","key":"10.1016\/j.bpa.2009.09.004_bib49","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2165\/00003495-200868120-00007","article-title":"Dabigatran etexilate","volume":"68","author":"Sanford","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.bpa.2009.09.004_bib50","author":"Boehringer-Ingelheim"},{"key":"10.1016\/j.bpa.2009.09.004_bib51","first-page":"S48","article-title":"Regional anaesthesia and thromboembolism prophylaxis\/anticoagulation \u2013 revised recommendations of the German Society of Anaesthesiology and Intensive Care Medicine","volume":"48","author":"Gogarten","year":"2007","journal-title":"An\u00e4sthesiologie & Intensivmedizin"},{"issue":"6 Suppl","key":"10.1016\/j.bpa.2009.09.004_bib52","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: american college of chest physicians evidence-based clinical practice guidelines (8th ed.)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.bpa.2009.09.004_bib53","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinte.161.16.1952","article-title":"Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review","volume":"161","author":"Hull","year":"2001","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.bpa.2009.09.004_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpa.2007.09.004","article-title":"Antiplatelet therapy and coronary stents in perioperative medicine\u2013the two sides of the coin","volume":"22","author":"Metzler","year":"2008","journal-title":"Best Practice & Research Clinical Anaesthesiology"},{"issue":"20","key":"10.1016\/j.bpa.2009.09.004_bib55","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"9665","key":"10.1016\/j.bpa.2009.09.004_bib56","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bpa.2009.09.004_bib57","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/13543784.15.12.1627","article-title":"Prasugrel","volume":"15","author":"Tantry","year":"2006","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"7","key":"10.1016\/j.bpa.2009.09.004_bib58","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/dmd.106.014522","article-title":"The disposition of prasugrel, a novel thienopyridine, in humans","volume":"35","author":"Farid","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.bpa.2009.09.004_bib59","author":"Lilly"},{"issue":"2","key":"10.1016\/j.bpa.2009.09.004_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/mhj.2000.107554","article-title":"Thrombocytopenia complicating treatment with intravenous glycoprotein IIb\/IIIa receptor inhibitors: a pooled analysis","volume":"140","author":"Dasgupta","year":"2000","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1016\/j.bpa.2009.09.004_bib61","first-page":"187","article-title":"Platelet glycoprotein IIb\/IIIa inhibition and its clinical use","volume":"2","author":"Huang","year":"2004","journal-title":"Current Medicinal Chemistry. Cardiovascular and Hematological Agents"},{"issue":"1","key":"10.1016\/j.bpa.2009.09.004_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beha.2004.02.001","article-title":"Foundation and sites of action of antithrombotic agents","volume":"17","author":"Marder","year":"2004","journal-title":"Best Practice & Research. Clinical Haematology"},{"issue":"5","key":"10.1016\/j.bpa.2009.09.004_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.mca.0000085884.61165.b0","article-title":"Assessing platelet function during treatment with glycoprotein IIb\/IIIa antagonists","volume":"14","author":"Steinhubl","year":"2003","journal-title":"Coronary Artery Disease"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689609000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689609000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:14:53Z","timestamp":1776410093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689609000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1521689609000688"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2009.09.004","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional anaesthesia and anticoagulation","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2009.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}